CHANGE HEALTHCARE INC (CHNG) Forecast, Price Target & Analyst Ratings

NASDAQ:CHNG • US15912K1007

27.49 USD

+0.07 (+0.26%)

At close: Sep 30, 2022

27.45 USD

-0.04 (-0.15%)

After Hours: 9/30/2022, 8:12:24 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHANGE HEALTHCARE INC (CHNG).

Consensus Price Target

Price Target

$27.85

+ 1.32% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Nov 2, 2022
Period: Q2 / 2023
EPS Estimate: $0.45
Revenue Estimate: 932.868M

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

71.76%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$27.85

Upside

+ 1.32%

From current price of $27.49 to mean target of $27.85, Based on 17 analyst forecasts

Low

$26.01

Median

$28.31

High

$29.14

Price Target Revisions

1 Month

N/A

3 Months

N/A

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for CHNG. The average price target is 27.85 USD. This implies a price increase of 1.32% is expected in the next year compared to the current price of 27.49.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

71.76%

CHNG was analyzed by 16 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about CHNG.

In the previous month the buy percentage consensus was at a similar level.

CHNG was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2022-09-20	Piper Sandler	Downgrade	Overweight -> Neutral
2022-09-20	Citigroup	Downgrade	Buy -> Neutral
2022-09-07	Truist Securities	Initiate	Hold
2022-06-01	Citigroup	Maintains	Buy
2022-05-31	Credit Suisse	Maintains	Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date: Nov 2, 2022
Period: Q2 / 2023
EPS Estimate: $0.45
Revenue Estimate: 932.868M
Revenue Q2Q: 12.83%
EPS Q2Q: 27.65%
Number of Analysts: 8

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

N/A

EPS (3 Months)

N/A

Next Earnings Summary

CHNG is expected to report earnings on 11/2/2022. The consensus EPS estimate for the next earnings is 0.45 USD and the consensus revenue estimate is 932.87M USD.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2020	2021	2022	2023	2024	2025	2026	2027
Revenue YoY % growth	3.303B 0.65%	3.09B -6.44%	3.481B 12.63%	3.647B 4.78%	3.781B 3.68%	4.015B 6.18%	4.13B 2.87%	4.334B 4.93%
EBITDA YoY % growth	780.5M 18.19%	633.2M -18.87%	822.128M 29.84%	1.094B 33.01%	1.177B 7.62%	1.265B 7.48%	1.334B 5.44%	1.434B 7.55%
EBIT YoY % growth	450.2M 22.44%	40.9M -90.92%	136.811M 234.50%	280.937M 105.35%	349.797M 24.51%	446.163M 27.55%	551.274M 23.56%	694.771M 26.03%
Operating Margin	13.63%	1.32%	3.93%	7.70%	9.25%	11.11%	13.35%	16.03%
EPS YoY % growth	1.58	1.33 -15.82%	1.51 13.53%	1.49 -1.57%	1.73 16.43%	2.01 16.14%	2.29 14.00%	2.66 16.28%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q2 / 23	Q3 / 23	Q4 / 23	Q1 / 24	Q2 / 24	Q3 / 24	Q4 / 24	Q1 / 25
EPS Q2Q % growth	0.45 27.65%	0.36 0.21%	0.42 7.49%	0.52 35.64%	0.54 21.00%	0.47 31.48%	0.53 25.30%	0.60 16.76%
Revenue Q2Q % growth	932.868M 12.83%	886.645M 2.38%	941.738M 2.35%	1.014B 14.62%	991.491M 6.28%	945.693M 6.66%	1.007B 6.95%	1.074B 5.95%
EBITDA Q2Q % growth	298.136M -13.43%	258.646M -51.54%	287.436M -61.06%	330.476M 65.01%	325.278M 9.10%	290.751M 12.41%	316.2M 10.01%	352.155M 6.56%
EBIT Q2Q % growth	63.036M 466.26%	17.799M -38.00%	43.401M -17.85%	89.454M 228.24%	97.92M 55.34%	45.9M 157.88%	71.4M 64.51%	129.54M 44.81%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

10.00%

EPS Next 5 Year

12.03%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

4.45%

Revenue Next 5 Year

4.23%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

N/A

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CHANGE HEALTHCARE INC / CHNG Forecast FAQ

What is the average price target for CHANGE HEALTHCARE INC (CHNG) stock?

17 analysts have analysed CHNG and the average price target is 27.85 USD. This implies a price increase of 1.32% is expected in the next year compared to the current price of 27.49.

Can you provide the upcoming earnings date for CHANGE HEALTHCARE INC?

CHANGE HEALTHCARE INC (CHNG) will report earnings on 2022-11-02, after the market close.

Can you provide the consensus estimates for CHANGE HEALTHCARE INC next earnings?

The consensus EPS estimate for the next earnings of CHANGE HEALTHCARE INC (CHNG) is 0.45 USD and the consensus revenue estimate is 932.87M USD.

What is the expected long term growth rate for CHNG stock?

The expected long term growth rate for CHANGE HEALTHCARE INC (CHNG) is 4.45%.

Analyst forecast overview

Forecast Snapshot